| Serial Number | 98738213 |
| Word Mark | NURIX |
| Filing Date | Friday, September 6, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, November 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 15, 2025 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields |
| Goods and Services | Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders |
| Description of Mark | The mark consists of a literal element NURIX with the letter N in an intersecting square design. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 6, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nurix Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Party Name | Nurix Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94158 |
| Event Date | Event Description |
| Friday, September 6, 2024 | NEW APPLICATION ENTERED |
| Wednesday, March 19, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 19, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, March 19, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 19, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 19, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 19, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 20, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 10, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 20, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 20, 2025 | SOU EXTENSION 1 FILED |
| Friday, November 21, 2025 | SOU EXTENSION 1 GRANTED |
| Friday, November 21, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 25, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, November 25, 2025 | TEAS STATEMENT OF USE RECEIVED |